title: Clinical Significance of a Positive Antinuclear Antibody Test.
authors: Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
authors: Gita
authors: G
authors: Fatemi
authors: Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
authors: Tanaz A
authors: TA
authors: Kermani
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood* / Q000187:drug effects; D018771:Arthralgia / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D005221:Fatigue / Q000097:blood / Q000276:immunology*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D011237:Predictive Value of Tests; D011720:Pyrazoles / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013954:Thyroglobulin / Q000276:immunology
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D015415:Biomarkers; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; C006606:anti-thyroglobulin; D013954:Thyroglobulin; D000068579:Celecoxib